-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Phio Pharmaceuticals Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Phio Pharmaceuticals Corp. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.91M, a 24.9% increase year-over-year.
- Phio Pharmaceuticals Corp. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$8.8M, a 29.3% increase year-over-year.
- Phio Pharmaceuticals Corp. annual Operating Income (Loss) for 2023 was -$10.8M, a 5.57% increase from 2022.
- Phio Pharmaceuticals Corp. annual Operating Income (Loss) for 2022 was -$11.5M, a 15.2% increase from 2021.
- Phio Pharmaceuticals Corp. annual Operating Income (Loss) for 2021 was -$13.5M, a 53.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)